are there any side effects to glp 1 GLP-1 Statistics 2026 | Nausea, Muscle Loss & Discontinuation Data From nausea and exhaustion to

The FDA hasnt approved GLP-1 agonists for the treatment of T1D

However, a slight increase in OCD risk was observed, and no significant associations were identified for broad depression, major depressive disorder, anorexia nervosa, or self-harm

It should cite the FDA-approved indication, your specific clinical criteria, prior failed therapies with dates, and the clinical rationale for the requested medication

Given the increasing interest in the potential use of incretins in cardiovascular diseases, conducting randomized controlled trials in this direction is warranted

PLoS One 8 : e65646

These agonists not only enhance GLP-1 release but also suppress the expression of pro-inflammatory cytokines, including IL-2, IL-17a, interferon-, and TNF- (Yusta et al., 2015)